HIV type 2 epidemic in Spain: challenges and missing opportunities
HIV type 2 (HIV-2) is a neglected virus despite estimates of 1–2 million people infected worldwide. HIV-2 is less efficiently transmitted than HIV-1 by sex and from mother to child. Although AIDS may develop in HIV-2 carriers, it takes longer than in HIV-1-infected patients. In contrast with HIV-1 infection, there is no global pandemic caused by HIV-2, as the virus is largely confined to West Africa. In a less extent and due to socioeconomic ties and wars, HIV-2 is prevalent in Portugal and its former colonies in Brazil, India, Mozambique and Angola. Globally, HIV-2 infections are steadily declining over time. A total of 338 cases of HIV-2 infection had been reported at the Spanish HIV-2 registry until December 2016, of whom 63% were men. Overall 72% were sub-Saharan Africans, whereas 16% were native Spaniards. Dual HIV-1 and HIV-2 coinfection was found in 9% of patients. Heterosexual contact was the most likely route of HIV-2 acquisition in more than 90% of cases. Roughly one-third presented with CD4 cell counts less than 200 cells/μl and/or AIDS clinical events. Plasma HIV-2 RNA was undetectable at baseline in 40% of patients. To date, one-third of HIV-2 carriers have received antiretroviral therapy, using integrase inhibitors 32 individuals. New diagnoses of HIV-2 in Spain have remained stable since 2010 with an average of 15 cases yearly. Illegal immigration from Northwestern African borders accounts for over 75% of new HIV-2 diagnoses. Given the relatively large community of West Africans already living in Spain and the continuous flux of immigration from endemic regions, HIV-2 infection either alone or as coinfection with HIV-1 should be excluded once in all HIV-seroreactive persons, especially when showing atypical HIV serological profiles, immunovirological disconnect (CD4 cell count loss despite undetectable HIV-1 viremia) and/or high epidemiological risks (birth in or sex partners from endemic regions)..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Aids |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
de Mendoza, Carmen [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| RVK: |
|---|
| doi: |
10.1097/QAD.0000000000001485 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1995044687 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1995044687 | ||
| 003 | DE-627 | ||
| 005 | 20230511183233.0 | ||
| 007 | tu | ||
| 008 | 170721s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1097/QAD.0000000000001485 |2 doi | |
| 028 | 5 | 2 | |a PQ20171125 |
| 035 | |a (DE-627)OLC1995044687 | ||
| 035 | |a (DE-599)GBVOLC1995044687 | ||
| 035 | |a (PRQ)w855-aca3d5ac9255426013f3436757635c0473ff32d936a8b45b63c3febea83d87470 | ||
| 035 | |a (KEY)0157957620170000031001001353hivtype2epidemicinspainchallengesandmissingopportu | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 084 | |a XA 16838 |q AVZ |2 rvk | ||
| 084 | |a 44.78 |2 bkl | ||
| 100 | 1 | |a de Mendoza, Carmen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV type 2 epidemic in Spain: challenges and missing opportunities |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a HIV type 2 (HIV-2) is a neglected virus despite estimates of 1–2 million people infected worldwide. HIV-2 is less efficiently transmitted than HIV-1 by sex and from mother to child. Although AIDS may develop in HIV-2 carriers, it takes longer than in HIV-1-infected patients. In contrast with HIV-1 infection, there is no global pandemic caused by HIV-2, as the virus is largely confined to West Africa. In a less extent and due to socioeconomic ties and wars, HIV-2 is prevalent in Portugal and its former colonies in Brazil, India, Mozambique and Angola. Globally, HIV-2 infections are steadily declining over time. A total of 338 cases of HIV-2 infection had been reported at the Spanish HIV-2 registry until December 2016, of whom 63% were men. Overall 72% were sub-Saharan Africans, whereas 16% were native Spaniards. Dual HIV-1 and HIV-2 coinfection was found in 9% of patients. Heterosexual contact was the most likely route of HIV-2 acquisition in more than 90% of cases. Roughly one-third presented with CD4 cell counts less than 200 cells/μl and/or AIDS clinical events. Plasma HIV-2 RNA was undetectable at baseline in 40% of patients. To date, one-third of HIV-2 carriers have received antiretroviral therapy, using integrase inhibitors 32 individuals. New diagnoses of HIV-2 in Spain have remained stable since 2010 with an average of 15 cases yearly. Illegal immigration from Northwestern African borders accounts for over 75% of new HIV-2 diagnoses. Given the relatively large community of West Africans already living in Spain and the continuous flux of immigration from endemic regions, HIV-2 infection either alone or as coinfection with HIV-1 should be excluded once in all HIV-seroreactive persons, especially when showing atypical HIV serological profiles, immunovirological disconnect (CD4 cell count loss despite undetectable HIV-1 viremia) and/or high epidemiological risks (birth in or sex partners from endemic regions). | ||
| 540 | |a Nutzungsrecht: Copyright © 2017 Wolters Kluwer Health, Inc. | ||
| 700 | 1 | |a Cabezas, Teresa |4 oth | |
| 700 | 1 | |a Caballero, Estrella |4 oth | |
| 700 | 1 | |a Requena, Silvia |4 oth | |
| 700 | 1 | |a Amengual, María J |4 oth | |
| 700 | 1 | |a Peñaranda, María |4 oth | |
| 700 | 1 | |a Sáez, Ana |4 oth | |
| 700 | 1 | |a Tellez, Raquel |4 oth | |
| 700 | 1 | |a Lozano, Ana B |4 oth | |
| 700 | 1 | |a Treviño, Ana |4 oth | |
| 700 | 1 | |a Ramos, José M |4 oth | |
| 700 | 1 | |a Pérez, José L |4 oth | |
| 700 | 1 | |a Barreiro, Pablo |4 oth | |
| 700 | 1 | |a Soriano, Vicente |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Aids <London> |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1987 |g 31(2017), 10, Seite 1353-1364 |w (DE-627)168132583 |w (DE-600)639076-6 |w (DE-576)015929418 |x 0269-9370 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2017 |g number:10 |g pages:1353-1364 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1097/QAD.0000000000001485 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2414 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 16838 |
| 936 | b | k | |a 44.78 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 31 |j 2017 |e 10 |h 1353-1364 | ||